Home / Tag Archives: Outperform

Tag Archives: Outperform

Stock upgrades and downgrades for 2Q 2022

upgrades and downgrades (2) Outperform

Stock upgrades and downgrades for 2Q 2022. Oppenheimer Initiated Rain Therapeutics (RAIN) at Outperform

Read More »

Stock upgrades and downgrades January 2021

upgrades and downgrades

DA Davidson Keeps the Buy Rating on Apple and raised the Price Target to $167 Wedbush Morgan Securities Inc. have an Outperform rating on Alphabet A (GOOGL)

Read More »

Bind Therapeutics BIND Price Targets

Bind Therapeutics BIND Price Targets: • Credit Suisse starts the shares at Outperform. Price target is $21. • Cowen initiates at Outperform with a $30 price target. • Stifel starts BIND at Buy. Price target is $20. • JMP initiates at Market Outperform. Price target is $30.

Read More »